Invitation to presentation in connection with EQL Pharma's quarterly report, third quarter, 2022/23
EQL Pharma AB (publ) will publish its quarterly report for the third quarter, 2022/23, on Tuesday, February 14[th], before stock markets opening.
At 10.00 (CET) 14[th] February, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the quarterly report. After the presentation, there is an opportunity to ask questions for those who participate.